HOUSTON--(BUSINESS WIRE)--Dec. 22, 2005--CytoGenix, Inc. (OTCBB:CYGX) announced that the prototype version of the synDNA(TM) production module was completed on schedule. The device was designed...
HOUSTON--(BUSINESS WIRE)--Dec. 20, 2005--CytoGenix, Inc. (OTCBB:CYGX) announced today that a suit brought by the US Virgin Island firm of Phanuel Pursuits, L.L.C. against CytoGenix, Inc., the...
HOUSTON & FARGO, N.D.--(BUSINESS WIRE)--Dec. 19, 2005--CytoGenix, Inc. (OTCBB:CYGX) and Aldevron, LLC announced positive results of a pilot study using CytoGenix synDNA(TM) as the active ingredient...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Aug. 29, 2005--Dutton Associates updates its coverage of CytoGenix (OTCBB:CYGX) with its rating maintained at Speculative Buy and a price target of $.90....
HOUSTON--(BUSINESS WIRE)--Aug. 16, 2005--CytoGenix Inc. (OTCBB:CYGX) announced today the signing of a contract with the engineering firm of Alfa Laval Biokinetics for the design and construction of...
HOUSTON--(BUSINESS WIRE)--Aug. 9, 2005--CytoGenix Inc. (OTCBB:CYGX) announced that it has entered into a collaborative research agreement with Imperial College London for research studies using the...
HOUSTON & FARGO, N.D.--(BUSINESS WIRE)--Aug. 2, 2005--CytoGenix, Inc. (OTCBB:CYGX) and Aldevron announced today a collaboration to conduct experiments with a DNA vaccine produced using CytoGenix...
HOUSTON--(BUSINESS WIRE)--Aug. 2, 2005--CytoGenix, Inc. (OTCBB:CYGX) announced today publication in the August 2005 issue of the American Society of Microbiology journal, Antimicrobial Agents and...
HOUSTON--(BUSINESS WIRE)--July 28, 2005--CytoGenix, Inc. (OTCBB:CYGX) announces filing of a patent application with the US Patent and Trademark Office for an invention titled "Nucleotides for...
CytoGenix Announces Results of Annual Shareholder Meeting
CytoGenix, Inc. (OTCBB:CYGX) announced today the results of proposals considered at its annual meeting of stockholders held July 14, in...
CytoGenix Announces Testing of Synthetic DNA Vaccine Against Smallpox
HOUSTON
CytoGenix, Inc., Houston
Juan Ferreira, 800-677-5707
CytoGenix, Inc. (OTCBB:CYGX) announced that it has entered...